Sigyn Therapeutics (SIGY) EPS (Basic) (2017 - 2025)
Sigyn Therapeutics (SIGY) posted EPS (Basic) of -$0.36 for Q3 2025, up 60.14% sequentially from -$0.9 in Q2 2025, and up 61.8% YoY from -$0.22 in Q3 2024.
Sigyn Therapeutics (SIGY) EPS (Basic) (2017 - 2025) Analysis & Trends
Sigyn Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.36 in Q3 2025.
- Quarterly EPS (Basic) rose 61.8% year-over-year to -$0.36 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$2.01 (up 36.25% YoY) and the FY2024 annual result came in at -$2.51, up 33.47% from the prior year.
- EPS (Basic) grew to -$0.36 in Q3 2025 per SIGY's latest filing, from -$0.9 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.01 in Q1 2021 and troughed at -$1.07 in Q4 2023.
- A 5-year average of -$0.3 and a median of -$0.03 in 2021 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2023: EPS (Basic) jumped 96.09% in 2021, then sank 4553.26% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.03 in 2021, then jumped by 31.88% to -$0.02 in 2022, then tumbled by 4553.26% to -$1.07 in 2023, then soared by 63.29% to -$0.39 in 2024, then climbed by 8.16% to -$0.36 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.36, -$0.9, and -$0.42 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 0.18 |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | -0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.90 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | -0.39 |
| Sep 30, 2024 | -0.94 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -1.07 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | -0.02 |
| Dec 31, 2021 | -0.03 |
| Sep 30, 2021 | -0.02 |
| Jun 30, 2021 | -0.02 |
| Mar 31, 2021 | -0.01 |
| Dec 31, 2020 | -0.06 |